About International Cannabinoid-Derived Pharmaceuticals Summit

Name: International Cannabinoid-Derived Pharmaceuticals Summit
Start: 2018-12-10T00:00:00+00:00
End: 2018-12-12T00:00:00+00:00
Location: Hyatt Regency Boston

Up until now, attention has been highly fixated on ‘Medical cannabis’. Meanwhile Pharmaceutical Cannabinoids have made incredible progress, now academia and industry must unite to advance further. By providing the inaugural International Cannabinoid-Derived Pharmaceuticals Summit, we have created this opportunity.

Issues include formulating unique compounds that achieve required responses, that can be delivered effectively. Many also still face problems designing reliable clinical trials in a frequently changing regulatory environment. We’ll be sharing and discussing these issues in depth with industry leaders such as Adi Zulloff-Shani of Therapix and Catherine Jacobson of Tilray.

Speakers

Speaker

More...

Post/Register Your Event

Quick Links

Media Pack Download

Newsletters

Event Location Map

Hyatt Regency Boston, United States

Organizer Testimonials

<p>I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.</p>

Baoping Wang

Novo Nordisk (China) R&D Centre

<p>Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.</p>

Organized By:

Hanson Wade Ltd